MRI-Targeted, Systematic, or Combined Biopsy for Detecting Clinically Significant Prostate Cancer.

Saved in:
Bibliographic Details
Title: MRI-Targeted, Systematic, or Combined Biopsy for Detecting Clinically Significant Prostate Cancer.
Authors: Burk KS; Center for Evidence-Based Imaging, Brigham and Women's Hospital, Boston, Massachusetts; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts; Dana Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Quality and Safety Officer, Mass General Brigham, Boston, Massachusetts. Electronic address: kburk@bwh.harvard.edu., Naik S; Center for Evidence-Based Imaging, Brigham and Women's Hospital, Boston, Massachusetts; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Lacson R; Center for Evidence-Based Imaging, Brigham and Women's Hospital, Boston, Massachusetts; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Associate Director, Center for Evidence-Based Imaging, Brigham and Women's Hospital, Boston, Massachusetts., Tuncali K; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts; Dana Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Lee LK; Center for Evidence-Based Imaging, Brigham and Women's Hospital, Boston, Massachusetts; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts; Dana Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Director, MRI, Brigham and Women's Hospital, Boston, Massachusetts., Tempany C; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts; Dana Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Vice Chair, Radiology Research, Brigham and Women's Hospital, Boston, Massachusetts., Cole AP; Dana Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Trinh QD; Dana Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts; Director, Ambulatory Clinical Operations, and Co-Director, Prostate Cancer Program, Department of Urology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, Massachusetts., Kibel AS; Dana Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts; Chief, Urology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, Massachusetts., Khorasani R; Center for Evidence-Based Imaging, Brigham and Women's Hospital, Boston, Massachusetts; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts; Dana Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Vice Chair, Quality and Safety, Mass General Brigham; and Director, Center for Evidence-Based Imaging, Brigham and Women's Hospital, Boston, Massachusetts.
Source: Journal of the American College of Radiology : JACR [J Am Coll Radiol] 2023 Jul; Vol. 20 (7), pp. 687-695. Date of Electronic Publication: 2023 Jun 13.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101190326 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-349X (Electronic) Linking ISSN: 15461440 NLM ISO Abbreviation: J Am Coll Radiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-349X
DOI:10.1016/j.jacr.2023.02.034